Share Your Research, Maximize Your Social Impacts
Main Menu
Searching By
PARTNERS
Pharmacovigilance Under 2021 - Overview of Pharmacovigilance Under COVID-19 Live Webinar
Topics/Call fo Papers
Pharmacovigilance Under COVID-19 course will provide an overview of the COVID constraints placed great strains upon the Pharmacovigilance reporting requirements as staff were working remotely or sick with the COVID illness.
For Pharmacovigilance and QA personnel, this course aims to demonstrate what the new guidances allow in terms of pharmacovigilance activities that can be relaxed during COVID and how to achieve these exemptions while achieving compliance and noting any deviations to existing processes and training.
Periodic reporting
Expedited reporting
What the EU Regulations are for COVID pharmacovigilance
Speaker:
Graeme has been working as Head of Global Pharmacovigilance and EU QP PV for many large (and small) Pharma, and has been CEO for the last 17 years for PharSafer.
For Pharmacovigilance and QA personnel, this course aims to demonstrate what the new guidances allow in terms of pharmacovigilance activities that can be relaxed during COVID and how to achieve these exemptions while achieving compliance and noting any deviations to existing processes and training.
Periodic reporting
Expedited reporting
What the EU Regulations are for COVID pharmacovigilance
Speaker:
Graeme has been working as Head of Global Pharmacovigilance and EU QP PV for many large (and small) Pharma, and has been CEO for the last 17 years for PharSafer.
Other CFPs
- Post-Market Activities in the EU-MDR β A Detailed Analysis Virtual Training
- Non-conforming Materials in a Medical Device Company β dealing with in-house to field issues LiveWebinar
- FDA's Endotoxin Test Guidance for Human Parenteral Drugs, Biological Products and Medical Devices -Live Webinar
- From MDD to MDR: Full Training Suite Package
- COVID19 Legislative update
Last modified: 2021-04-05 14:45:11